Obesity and metabolic syndrome-related chronic kidney disease in nondiabetic, nonhypertensive adults

Metabolism: Clinical and Experimental

Volumn 58, Issue 12, 2009, Pages 1737-1742

  Yoon, Yeong Sook ^a   Park, Hye Soon ^b   Yun, Kyung Eun ^b   Kim, Soon Bae ^b  

^a Inje University College of Medicine   (South Korea)

^b University of Ulsan College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; FEMALE; GLOMERULUS FILTRATION RATE; HEALTH PROGRAM; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; PREVALENCE; PRIORITY JOURNAL;

ADULT; BODY MASS INDEX; CHRONIC DISEASE; FEMALE; HUMANS; KIDNEY DISEASES; KOREA; MALE; METABOLIC SYNDROME X; OBESITY; PHYSICAL EXAMINATION; QUESTIONNAIRES;

EID: 71849094204     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2009.05.029     Document Type: Article

References (36)

1. Go A.S., Chertow G.M., Fan D., McCulloch C.E., and Hsu C.Y. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351 (2004) 1296-1305
2. Kiberd B. The chronic kidney disease epidemic: stepping back and looking forward. J Am Soc Nephrol 17 (2006) 2967-2973
3. Weiner D.E., Tighiouart H., Amin M.G., Stark P.C., MacLeod B., and Griffith J.L. Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies. J Am Soc Nephrol 15 (2004) 1307-1315
4. Fox C.S., Larson M.G., Leip E.P., Culleton B., Wilson P.W., and Levy D. Predictors of new-onset kidney disease in a community-based population. JAMA 291 (2004) 844-850
5. Ejerblad E., Fored C.M., Lindblad P., Fryzek J., McLaughlin J.K., and Nyren O. Obesity and risk for chronic renal failure. J Am Soc Nephrol 17 (2006) 1695-1702
6. Hsu C.Y., McCulloch C.E., Iribarren C., Darbinian J., and Go A.S. Body mass index and risk for end-stage renal disease. Ann Intern Med 144 (2006) 21-28
7. Iseki K., Ikemiya Y., Kinjo K., Inoue T., Iseki C., and Takishita S. Body mass index and the risk of development of end-stage renal disease in a screened cohort. Kidney Int 65 (2004) 1870-1876
8. Chen J., Gu D., Chen C.S., Wu X., Hamm L.L., and Muntner P. Association between the metabolic syndrome and chronic kidney disease in Chinese adults. Nephrol Dial Transplant 22 (2007) 1100-1106
9. Chen J., Muntner P., Hamm L.L., Jones D.W., Batuman V., and Fonseca V. The metabolic syndrome and chronic kidney disease in U.S. adults. Ann Intern Med 140 (2004) 167-174
10. Tozawa M., Iseki C., Tokashiki K., Chinen S., Kohagura K., and Kinjo K. Metabolic syndrome and risk of developing chronic kidney disease in Japanese adults. Hypertens Res 30 (2007) 937-943
11. Zhang L., Zuo L., Wang F., Wang M., Wang S., and Liu L. Metabolic syndrome and chronic kidney disease in a Chinese population aged 40 years and older. Mayo Clin Proc 82 (2007) 822-827
12. Kitiyakara C., Yamwong S., Cheepudomwit S., Domrongkitchaiporn S., Unkurapinun N., and Pakpeankitvatana V. The metabolic syndrome and chronic kidney disease in a Southeast Asian cohort. Kidney Int 71 (2007) 693-700
13. Kurella M., Lo J.C., and Chertow G.M. Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults. J Am Soc Nephrol 16 (2005) 2134-2140
14. Rashidi A., Ghanbarian A., and Azizi F. Are patients who have metabolic syndrome without diabetes at risk for developing chronic kidney disease? Evidence based on data from a large cohort screening population. Clin J Am Soc Nephrol 2 (2007) 976-983
15. Kanauchi M., Kanauchi K., Kimura K., Inoue T., and Saito Y. Associations of chronic kidney disease with the metabolic syndrome in non-diabetic elderly. Nephrol Dial Transplant 21 (2006) 3608-3609
16. Lee J.E., Choi S.Y., Huh W., Kim Y.G., Kim D.J., and Oh H.Y. Metabolic syndrome, C-reactive protein, and chronic kidney disease in nondiabetic, nonhypertensive adults. Am J Hypertens 20 (2007) 1189-1194
17. Sedor J.R., and Schelling J.R. Association of metabolic syndrome in nondiabetic patients with increased risk for chronic kidney disease: the fat lady sings. J Am Soc Nephrol 16 (2005) 1880-1882
18. Stengel B., Jaussent I., Guiserix J., Bourgeon B., Papoz L., and Favier F. High prevalence of chronic kidney disease in La Reunion island and its association with the metabolic syndrome in the non-diabetic population: La Reunion Diabetes (REDIA) Study. Diabetes Metab 33 (2007) 444-452
19. Gatti A., Morini E., Cosmo S.D., Maiani F., Mandosi E., and Fallarino M. Metabolic syndrome is not a risk factor for kidney dysfunction in obese non-diabetic subjects. Obesity 16 (2008) 899-901
20. Grundy S.M., Cleeman J.I., Daniels S.R., Donato K.A., Eckel R.H., and Franklin B.A. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112 (2005) 2735-2752
21. World. Health Organization Western Pacific Region. International Association for the Study of Obesity, International Obesity Task Force. The Asia-Pacific perspective: redefining obesity and its treatment (2000), Health Communications Australia Pty Limited, Sydney
22. Levey A.S., Bosch J.P., Lewis J.B., Greene T., Rogers N., and Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130 (1999) 461-470
23. Chagnac A., Weinstein T., Korzets A., Ramadan E., Hirsch J., and Gafter U. Glomerular hemodynamics in severe obesity. Am J Physiol Renal Physiol 278 (2000) F817-F822
24. Chang C.J., Wu C.H., Chang C.S., Yao W.J., Yang Y.C., and Wu J.S. Low body mass index but high percent body fat in Taiwanese subjects: implications of obesity cutoffs. Int J Obes Relat Metab Disord 27 (2003) 253-259
25. Deurenberg P., Deurenberg-Yap M., and Guricci S. Asians are different from Caucasians and from each other in their body mass index/body fat per cent relationship. Obes Rev 3 (2002) 141-146
26. Dhiman R.K., Duseja A., and Chawla Y. Asians need different criteria for defining overweight and obesity. Arch Intern Med 165 (2005) 1069-1070
27. Korean. Ministry of Health and Welfare. The Korean National Health Nutrition Examination Survey 2005 (2006), Korean Ministry of Health and Welfare, Seoul
28. Kamijo A., Kimura K., Sugaya T., Yamanouchi M., Hase H., and Kaneko T. Urinary free fatty acids bound to albumin aggravate tubulointerstitial damage. Kidney Int 62 (2002) 1628-1637
29. Wisse B.E. The inflammatory syndrome: the role of adipose tissue cytokines in metabolic disorders linked to obesity. J Am Soc Nephrol 15 (2004) 2792-2800
30. Bavbek N., Isik B., Kargili A., Uz E., Uz B., Kanbay M., et al. Association of obesity with inflammation in occult chronic kidney disease. J Nephrol. 21 (2008) 761-767
31. Ramkumar N., Cheung A.K., Pappas L.M., Roberts W.L., and Beddhu S. Association of obesity with inflammation in chronic kidney disease: a cross sectional study. J Ren Nutr 14 (2004) 201-207
32. Abrass C.K., Raugi G.J., Gabourel L.S., and Lovett D.H. Insulin and insulin-like growth factor I binding to cultured rat glomerular mesangial cells. Endocrinology 123 (1988) 2432-2439
33. Cusumano A.M., Bodkin N.L., Hansen B.C., Iotti R., Owens J., and Klotman P.E. Glomerular hypertrophy is associated with hyperinsulinemia and precedes overt diabetes in aging rhesus monkeys. Am J Kidney Dis 40 (2002) 1075-1085
34. Chen J., Muntner P., Hamm L.L., Fonseca V., Batuman V., and Whelton P.K. Insulin resistance and risk of chronic kidney disease in nondiabetic US adults. J Am Soc Nephrol 14 (2003) 469-477
35. Fried L.F., Orchard T.J., and Kasiske B.L. Effect of lipid reduction on the progression of renal disease: a meta-analysis. Kidney Int 59 (2001) 260-269
36. Kasiske B.L., O'Donnell M.P., Cleary M.P., and Keane W.F. Treatment of hyperlipidemia reduces glomerular injury in obese Zucker rats. Kidney Int 33 (1988) 667-672